Naimish Patel is Chief Medical Officer at CRISPR Therapeutics AG (CRSP). They have made 4 open-market trades across 1 company since 2025, most recently 2026-05-29.
CIK 0002021679
1 open-market purchase totalling $50K since 2025, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRSP | 19,357 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2026-06-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.